Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Alliant Energy Corporation (LNT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Alliant Energy Corporation — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.19 (market cap $12.58B), while Alliant Energy Corporation trades at $65.75 (market cap $16.99B). The key difference: Alliant Energy Corporation is the larger of the two by market cap, and Alliant Energy Corporation pays a 3.27% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and Alliant Energy Corporation for 64 Days on average.
| HALO | LNT | |
|---|---|---|
Market Cap | $12.58B | $16.99B |
Volume | 2,179,278 | 2,488,387 |
Sector | Health | Utilities |
52-Week High | $115.22 | $78.03 |
52-Week Low | $61.63 | $63.21 |
Typical Hold Time | 0 Days | 64 Days |
Enterprise Value | $14.49B | $29.08B |
Dividend Yield | — | 3.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LNT trades at $65.21, down 0.43% on the day, with a bullish technical signal despite mixed indicators. The company reported Q2 2026 EPS of $0.65, beating estimates, and maintains a strong profitability profile with an 18.45% net income margin. Recent news highlights institutional buying and a $1.4 billion partnership expansion, though the stock recently touched a 52-week low.
The outlook is supported by a $13.4 billion capital investment plan and data center demand growth, offering potential upside to the $77 consensus price target. Risks include rising debt levels and cost pressures, but analyst sentiment remains positive with no sell ratings. The stock presents a defensive income opportunity with a growing dividend.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →
